Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Paragraph: The public-private partnership includes the World Health Organization, UNICEF, the Bill & Melinda Gates Foundation and the World Bank, among others. The funding announcement was made after a meeting of GAVI’s board. GAVI said the investment, which it called an estimate, will be provided between now and 2025. Since the current outbreak in eastern Congo was identified last August, health officials have immunized more than 255,000 people with a recently licensed vaccine made by Merck. To date there have been nearly 3,200 confirmed Ebola cases, including more than 2,200 deaths, in what has become the second deadliest Ebola outbreak in history. Dr. Ngozi Okonjo-Iweala, chair of Gavi’s board, called the creation of the Ebola vaccine stockpile a “historic milestone in humanity’s fight against this horrific disease.” GAVI said “a coordinating mechanism” to decide how and when vaccines will be used will be established with partner organizations. There are similar stockpiles for vaccines against yellow fever, meningitis and cholera. Those limited shots are doled out to developing countries by WHO, UNICEF, the Red Cross and Doctors Without Borders after receiving technical advice from others. The Ebola vaccine stockpile will be available to all countries, but only developing countries will be able to get vaccines for free in addition to support for the logistical costs of mounting vaccination campaigns. Jason Nickerson, a humanitarian affairs adviser at Doctors Without Borders, said the new stockpile would change how officials respond to future Ebola outbreaks. “Knowing how many doses of the vaccine exist in the world, and then being able to get a supply of them to high-risk countries in a very quick way, gives us another tool to respond to these outbreaks,” he said. Earlier this year, the medical charity publicly called for an independent committee to oversee Ebola vaccination efforts in Congo, saying WHO sometimes used arbitrary criteria to determine who would get immunized. It said the fact that Ebola was continuing to spread despite the large number of people vaccinated was a damning assessment of the response. Containing this outbreak has been complicated by violence and misunderstandings in a part of Congo that had never reported an Ebola case before. Last week, response activities were suspended after attacks killed four Ebola responders, including a member of a vaccination team. Multiple rebel groups operate in eastern Congo and the region has been described as a war zone. WHO has warned continued attacks on health workers and Ebola clinics could undermine attempts to curb Ebola and prompt a resurgence of the disease. Claim: Vaccine group announces creation of Ebola vaccine stockpile.
The vaccine alliance GAVI announced Thursday it would invest $178 million to create a global stockpile of about 500,000 Ebola vaccines, a decision that health officials say could help prevent future outbreaks from spiraling out of control.

Paragraph: “I could not go to the DRC (Congo) without coming to meet the brave inhabitants of this beautiful territory,” U.N. chief Antonio Guterres said. “There are major concerns about health. There is measles, malaria, cholera and now the terrible drama of Ebola. We are fully on the side of the Congolese people to try to meet all these challenges.” Guterres also pledged the U.N. peacekeeping forces’ support with the armed forces of Congo in the fight against extremism “that is threatening not only Congo but Africa and the world.” He is on a three-day trip to Congo. He stopped in Goma earlier and on Monday will meet with Congo’s President Felix Tshisekedi. “It is important for the people of Beni to know that we have heard their cries of distress. The United Nations as a whole is committed to supporting the Congolese authorities, local communities and civil society actors in the fight against insecurity,” he said while in Beni, adding that he will discuss these issues when he visits Kinshasa on Monday. Guterres’ trip comes as Ebola cases are about the topple 3,000 along with nearly 2,000 deaths in eastern Congo since the outbreak was declared a year ago. Health authorities have faced major challenges trying to stem the spread of the disease amid insecurity and mistrust from communities. Traumatized by Ugandan Allied Democratic Forces rebels since October 2014, residents of Beni say they do not trust the U.N. peacekeepers, who they say have done little to protect them from rebel attacks. The region is home to numerous rebel groups vying for control of the mineral-rich land. “Imagine rebels attacking in the evening but we try to call MONUSCO but they arrive in the morning with cameras,” said Nzanu Nzoli a former resident of the town of Eringeti who traveled to Beni to flee the attacks. “The visit of Antonio Guterres will not change the current state of our situation in Beni because before him we had already received the promises of the Congolese government and the U.N. ... But it will soon be five years without action. ... Nothing will change.” Others in the area said a visit from the head of the U.N. could boost military operations. “I believe that with his visit ... Antonio Guterres will learn about the current situation of the rebels, and the evolution of Ebola. Often he receives reports but he will feel the situation, so I hope for a favorable outcome,” said Kambale Mundoleko, an Ebola survivor near Beni in Mangina who lost her entire family. Upon his arrival in Mangina, Guterres visited an Ebola treatment center and also witnessed the unloading of four Ebola patients. Claim: UN chief visits Congo Ebola region, pledging support.
The United Nations secretary general visited Congo’s eastern city of Beni on Sunday, pledging solidarity as the region faces an Ebola outbreak that has killed nearly 2,000 people in a year and ongoing insecurity that has residents skeptical of outside help.

Paragraph: Researchers around the world are working to develop potential treatments or vaccines against the respiratory disease that has killed nearly 47,000 people and infected almost a million in just a few months. A team at the University of Pittsburgh School of Medicine in the United States said they were able to move quickly in developing a potential COVID-19 vaccine after working on other coronaviruses that cause Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). “These two viruses, which are closely related to SARS-CoV-2 (the new coronavirus causing the COVID-19 pandemic), teach us that a particular protein, called a spike protein, is important for inducing immunity against the virus,” said Andrea Gambotto, an associate professor at Pittsburgh. “We knew exactly where to fight this new virus.”  When tested in mice, the prototype vaccine - which the researchers have called PittCoVacc - generated what they described as “a surge of antibodies” against the new coronavirus  within two weeks. The Pittsburgh researchers cautioned that because the animals have not been tracked for very long as yet, it is too early to say whether and for how long the immune response against COVID-19 lasts. But they said that in comparable tests in mice with their MERS experimental vaccine, a sufficient level of antibodies was produced to neutralize the virus for at least a year. So far, the antibody levels of the SARS-CoV-2 vaccinated animals seem to be following the same trend, they said in peer-reviewed study in the journal EBioMedicine. The team said they hope to start testing the vaccine candidate on people in clinical trials in the next few months. The potential vaccine uses a needle patch design, called a microneedle array, to increase its potential potency. This array is a fingertip-sized patch of 400 tiny needles made out of sugar and the spike protein, Gambotto explained. It is designed to deliver the spike protein pieces into the skin, where the immune reaction is strongest. Claim: Potential COVID-19 vaccine shows promise in mouse study.

Initial tests in mice of a potential COVID-19 vaccine delivered via a fingertip-sized patch have shown it can induce an immune response against the new coronavirus at levels that might prevent infection, U.S. scientists said on Thursday.